title: In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.
authors.affiliation: aDepartment of Paediatric Hematology, Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Centre (AMC), University of Amsterdam (UvA), Amsterdam bDepartment of Paediatrics, Amphia Hospital, Breda cDepartment of Internal Medicine dDepartment of Gynaecology and Obstetrics, AMC, UvA eHIV Monitoring Foundation fDepartment of Experimental Immunology, AMC, UvA, Amsterdam, The Netherlands. *Henriette J. Scherpbier and Madeleine J. Bunders contributed equally to the writing of this article.
authors.forename: Lisanne
authors.initials: L
authors.lastname: Denneman
authors.forename: Sophie
authors.initials: S
authors.lastname: Cohen
authors.forename: Mieke H
authors.initials: MH
authors.lastname: Godfried
authors.forename: Elisabeth
authors.initials: E
authors.lastname: van Leeuwen
authors.forename: Jeannine F B
authors.initials: JF
authors.lastname: Nellen
authors.forename: Taco W
authors.initials: TW
authors.lastname: Kuijpers
authors.forename: Dasja
authors.initials: D
authors.lastname: Pajkrt
authors.forename: Atie
authors.initials: A
authors.lastname: van de Plas
authors.forename: Colette
authors.initials: C
authors.lastname: Smit
authors.forename: Anouschka M
authors.initials: AM
authors.lastname: Weijsenfeld
authors.forename: Henriette J
authors.initials: HJ
authors.lastname: Scherpbier
authors.forename: Madeleine J
authors.initials: MJ
authors.lastname: Bunders
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001724:Birth Weight / Q000187:drug effects; D002657:Child Development / Q000187:drug effects; D005260:Female; D047109:Fetal Development / Q000187:drug effects; D005317:Fetal Growth Retardation / Q000139:chemically induced; D005500:Follow-Up Studies; D006130:Growth Disorders / Q000139:chemically induced*; D015658:HIV Infections / Q000188:drug therapy / Q000635:transmission*; D006801:Humans; D007223:Infant; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*; D012189:Retrospective Studies; D000068698:Tenofovir / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D019380:Anti-HIV Agents; D000068698:Tenofovir